Partner institutions


Cardiff University (CU) is the leading research university in Wales and a member of the Russell group (the leading research-intensive British universities). CU has an international reputation for innovation and leadership in the biomedical sciences, molecular and clinical genetics, and stem cell biology, and is investing heavily in this area with major new research institutes opening in 2013 in Cancer Stem Cells and in Neuroscience and Mental Health.
Principal investigators: Anne Rossler (Scientific Coordinator), Stephen B. Dunnett, Meng Li, Paul Kemp, Nicolas Allen, Monica BusseWilliam Gray .
Roslin Cells is a world leader in the isolation of new clinical grade pluripotent stem cells for use in research and therapy. Roslin Cells is committed to the development of new cell therapies. It seeks to do this by producing the highest quality pluripotent and multipotent stem cells and, in collaboration with others, developing the capacity to produce clinical grade cells of selected lineages in very large quantities.
Principal investigator:Paul de Sousa


The University of Manchester is Britain’s oldest civic university, and a member of the Russell Group of leading UK research-intensive universities. Genetic Medicine is situated within the Institute of Human Development, and is one of the largest Clinical Genetics research groups in Europe, providing care and research excellence to families affected by inherited diseases; The University of Manchester has strong links with the Institute of Brain, Behaviour and Mental Health, which has an international reputation in the field of dementia and neurodegeneration.
Principal investigator:David Craufurd       back to top                                               


The Institut national de la santé et de la recherche médicale (Inserm) is the only French public research body entirely dedicated to human health. Its researchers are committed to studying all diseases, whether common or rare, through their research in the fields of biology, medicine and public health.
Principal investigators:Anselme Perrier, Anne-Catherine Bachoud-Levi


CEA is a French government-funded technological research organisation.
A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world. It will be represented by the Molecular Imaging Research Centre (MIRCen), a research centre dedicated to the development of preclinical studies for drug, cell and gene-based therapies for the treatment of neurodegenerative diseases.
Principal Investigator:Philippe Hantraye




Inserm Transfert, a private subsidary of Inserm, is involved in the activities of intellectual property management, technology transfer and industrial partnerships. The goal is to shorten the time span between laboratory discoveries and the development of new health products for patients.
Project management Team:Christiane Dascher-Nadel; This email address is being protected from spambots. You need JavaScript enabled to view it.

 back to top



The George-Huntington-Institute (GHI) is devoted to clinical care and preclinical and clinical research in Huntington's disease. The GHI entertains one of the largest HD out-patient clinics for sympotmatic and premanifest gene carriers, persons at-risk and care-takers around the world. The GHI was founded in 2013 by Dr. Ralf Reilmann in Münster to extend the work initiated by him in 2001 at the University of Münster. The GHI is actively involved in several activities of the European Huntington's Disease Netzwork (EHDN).
Principal investigator: Ralf Reilmann



The Consortium for Research In Organ Transplantation and Regenerative Medicine (CORIT) was founded in Padova in 1997 and brings together public and private bodies operating directly or indirectly in the scientific research sector. The Consortium is a non-profit organisation, operating in the interests of the public. CORIT strives to promote scientific excellence in research in transplantation.
Principal investigator:Emanuele Cozzi

 back to top